Aptevo Therapeutics Inc (APVO) Stock Price, Quote, News & History

APVONASDAQ
$1.89
At close: Sep 24, 5:00 PM EST
$1.83
-0.062-3.28%
After Hours: 7:31 PM EST

Aptevo Therapeutics (APVO) Stock Price, Quote, News & History | Benzinga

60%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-25.34M
Investing Cash Flow (TTM)
0
Financing Cash Flow (TTM)
25.73M
Free Cash Flow (TTM)
-25.34M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
387.00K

Analyst Rating and Forecast

12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
-$2.17M
PE Ratio (TTM)
0.00
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
0.57
Earnings Yield % (TTM)
24159.79%
Earnings Yield % (FWD)
-348.68%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$3.34

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$9.80M
Debt to Equity
0.70
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
-
Close
-
Volume / Avg.
0 / 110.46K
Day Range
- - -
52 Wk Range
1.37 - 35.64
Market Cap
$3.29M
P/E Ratio
0.00
Dividend Yield
-
Exchange
NASDAQ
RSI
34
Short Interest
6.56%
Days to Cover
1.93

About

Sector
Health Care
Industry
Biotechnology
Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which target...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Aptevo Therapeutics (APVO) stock?

A

You can purchase shares of Aptevo Therapeutics (NASDAQ:APVO) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Aptevo Therapeutics (APVO) competitors?

Q

What is the forecast, or price target, for Aptevo Therapeutics (APVO) stock?

A

Aptevo Therapeutics has a consensus price target of $106560.00.

Q

What is the current price for Aptevo Therapeutics (APVO)?

A

The stock price for Aptevo Therapeutics (NASDAQ: APVO) is $1.828 last updated September 23, 2026 at 7:31 PM EDT.

Q

Does Aptevo Therapeutics (APVO) pay a dividend?

A

There are no upcoming dividends for Aptevo Therapeutics.

Q

When is Aptevo Therapeutics (NASDAQ:APVO) reporting earnings?

A

Aptevo Therapeutics does not have any upcoming earnings scheduled.

Q

Is Aptevo Therapeutics (APVO) going to split?

A

There is no upcoming split for Aptevo Therapeutics.

Q

What sector and industry does Aptevo Therapeutics (APVO) operate in?

A

Aptevo Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.